|
Originally published In Press as doi:10.1074/jbc.M205380200 on September 12, 2002
J. Biol. Chem., Vol. 277, Issue 47, 45195-45202, November 22, 2002
Suprabasin, a Novel Epidermal Differentiation Marker and
Potential Cornified Envelope Precursor*
Geon Tae
Park ,
Susan E.
Lim ,
Shyh-Ing
Jang§, and
Maria I.
Morasso ¶
From the Developmental Skin Biology Unit of the
§ Laboratory of Skin Biology, NIAMS, National Institutes of
Health, Bethesda, Maryland 20892
Received for publication, May 30, 2002, and in revised form, August 21, 2002
 |
ABSTRACT |
The suprabasin gene is a novel gene expressed in
mouse and human differentiating keratinocytes. We identified a partial
cDNA encoding suprabasin using a suppression subtractive
hybridization method between the proliferative basal and
differentiating suprabasal populations of the mouse epidermis. A 3'
gene-specific probe hybridized to transcripts of 0.7- and 2.2-kb pairs
on Northern blots with specific detection in differentiated
keratinocytes of stratified epithelia. The mouse gene was mapped to
chromosome 7 by fluorescence in situ hybridization. This
region is syntenic to human chromosome band 19q13.1, which contained
the only region in the data bases with homology to the mouse suprabasin
sequence. During embryonic mouse development, suprabasin mRNA was
detected at day 15.5, coinciding with epidermal stratification.
Suprabasin was detected in the suprabasal layers of the epithelia in
the tongue, stomach, and epidermis. Differentiation of cultured primary
epidermal keratinocytes with 0.12 mM Ca2+ or
12-O-tetradecanoylphorbol-13-acetate treatment resulted in the induction of suprabasin. The 2.2-kb cDNA transcript encodes a
protein of 72 kDa with a predicted isoelectric point of 6.85. The translated sequence has an amino-terminal domain, a central domain
composed of repeats rich in glycine and alanine, and a carboxyl-terminal domain. The alternatively spliced 0.7-kb transcript encodes a smaller protein that shares the NH2- and
COOH-terminal regions but lacks the repeat domain region. Cross-linking
experiments indicate that suprabasin is a substrate for
transglutaminase 2 and 3 activity. Altogether, these results indicate
that the suprabasin protein potentially plays a role in the process of
epidermal differentiation.
 |
INTRODUCTION |
Cells losing contact with the underlying basement membrane will
undergo differentiation to form the mature epidermis. During mouse
development, at day 14 the stratified epidermal layers begin to appear,
and the keratinocytes follow a complex program of differentiation with
the formation of the spinous and granular layers, leading to a highly
stratified, water impermeable barrier at birth on day 19 (1, 2). The
final phase of this complex differentiation program is the formation of
cornified envelopes (CE).1
This process includes granular cell death, destruction of all organelles, -( -glutamyl)lysine isopeptide covalent cross-linking of cornified envelope precursors through the action of
calcium-dependent transglutaminases (TGases), and
attachment of lipid molecules to the cross-linked envelope (3, 4).
In the last two decades, a group of epidermal-specific genes that are
components of the CE have been identified and characterized (reviewed
in Refs. 5-7). In humans, many of these epidermal genes are closely
linked in a 2.5-Mbp region, located in chromosome 1q21, that has been
termed the epidermal differentiation complex (EDC) (8). Several of the
reported mouse homolog genes have been mapped to the murine EDC in a
syntenic region of chromosome 3. Three types of protein families that
contribute to the cornification process are clustered in the EDC (9).
The first, with proteins such as involucrin, loricrin, late envelope
proteins, and small proline-rich proteins, is characterized by
relatively small sizes with short tandem peptide repeats in the central
region. The second family (fused-type), represented by profilaggrin and
repetin, has EF-hand domains (Ca2+-binding domains) at the
NH2-terminal region followed by multiple tandem repeats.
The third family is represented by members of the S100 family and is
characterized by presenting Ca2+-binding EF-hand domains.
There are other epidermal genes that are incorporated into the CE that
do not localize to the EDC, such as those for sciellin, envoplakin, and
periplakin (10-12). It has been proposed that the cell envelope
formation is a highly coordinated process in which cross-linking of
specific groups of proteins occur in a sequential order (4). In recent
reports from targeting experiments it has become clear that, in the
absence of major envelope precursor proteins, other factor(s) are able to substitute or replace their function to culminate in the formation of a normal or "quasi-normal" cornified envelope (13-16).
Recently, additional genes have been identified by different
approaches: subtractive hybridization, rapid analysis of gene
expression, positional cloning, and EST data base searches (17-21). It
has been hypothesized that some of these newly characterized proteins would be able to compensate in function for other well known CE precursors (13, 19).
The novel suprabasin, which we have characterized in this study, is
structurally similar to involucrin and loricrin; the open reading frame
codes for a small protein rich in glycine, with short tandem repeats in
the central region. The suprabasin gene is expressed in vivo
in the differentiating layers of cornifying epithelia, and the
expression can be induced in vitro by treatment of
keratinocytes with Ca2+ or with TPA, dependent on PKC
signaling. We propose that suprabasin is a new member of the
epidermal-specific proteins that is a substrate for TGase activity and
potentially plays a role in the epidermal differentiation process.
 |
EXPERIMENTAL PROCEDURES |
Suppression Subtractive Hybridization (SSH)--
SSH
(Clontech; Ref. 22) was performed following
instructions of the manufacturer using basal cell RNA as a "driver"
and suprabasal cell RNA as "tester." The primary mouse basal and
suprabasal keratinocytes were obtained from neonatal skins that were
trypsinized overnight at 4 °C, and separated by a discontinuous
Percoll gradient (23). From this screen, we identified a partial
cDNA sequence (262 bp) that corresponded to part of the
COOH-terminal end and 3'-untranslated region of suprabasin (nucleotides
2014-2277). The complete cDNA sequence was obtained performing
5'-rapid amplification of cDNA ends (RACE)
(Clontech). A canonical polyadenylation signal and
poly(A)+ tail were identified at the 3' end. The complete
mRNA sequence was deposited in GenBankTM (accession no.
AY115494).
Mapping of the Transcriptional Start Site--
To determine the
transcription start site, we performed the RACE method using the SMART
RACE cDNA amplification kit (Clontech). The
gene-specific oligonucleotide (5'-CTGCCCGGGCAGGCAGAGTCCC-3') utilized
was located at +100 bp from the putative translation initiation AUG in
the coding sequence of suprabasin. The final PCR product was cloned and
sequenced to determine the 5' mRNA sequence.
Cloning and Analysis of Suprabasin Genomic Sequence--
A
genomic DNA region of ~110 kb was cloned through screening of a mouse
VJ/129 BAC library (Genome Systems Inc.) using a 1.7-kb suprabasin
cDNA as a probe. To analyze the genomic structure of the suprabasin
gene, we performed PCR with the oligonucleotides corresponding to the
5' end and 3' end of cDNA and the BAC genomic DNA as a template.
Comparison of the genomic and cDNA sequences determined the
exon/intron boundaries and the sizes of intronic regions. To obtain
further 5' upstream and 3' downstream sequence, we used a
Chromosome Walking kit (Clontech) with
gene-specific primers and genomic mouse DNA following the instructions
specified by the manufacturer. We used BLAST analysis for sequence
homology searches, made available through the National Center for
Biotechnology Information (www.ncbi.nlm.nih.gov/BLAST/).
Chromosomal Localization by FISH--
The genomic mouse
suprabasin BAC clone was labeled with digoxigenin dUTP by nick
translation (carried out by Genome Systems Inc.). The labeled probe was
combined with sheared mouse DNA and hybridized to normal metaphase
chromosomes derived from mouse embryo fibroblast cells in a solution
containing 50% formamide, 10% dextran sulfate, and 2× SSC. Specific
hybridization signals were detected by incubating the hybridized slides
in fluoresceinated antidigoxigenin antibodies followed by
counterstaining with 4,6-diamidino-2-phenylindole.
Plasmids--
Constructs were prepared by cloning a
PCR-amplified coding region of suprabasin tagged with EcoRI
and SalI sites into pGEMT-easy (Promega; pGEM/suprabasin)
and pEGFP-C1 vector (Clontech; pGFP-suprabasin). The truncated sequences were generated by PCR using the following oligonucleotides: RI5'suprabasin
(5'-gcggaattctATGTATCTTGTCAGTTTGCTCAGCTCCTGC-3') and
462Rsuprabasin
(5'-gtggtcgacCCCCTGACCAAACTTCCCTGCTTCACTGCC-3') for
pGFP/suprabasin (aa 1-144); RI5'suprabasin and 1304Rsuprabasin (5'-gtggtcgacCAGCCCCTTGCACCAGTCTGCCTC-3') for
pGFP/suprabasin (aa 1-425); RI5'suprabasin and 1924Rsuprabasin
(5'-gaggtcgacTCATTTCCTGGCCAGCAGCATGGTGGACAC-3') for
pGFP/suprabasin (aa 1-612); 427Fsuprabasin
(5'-gaggaattctTCAGGGGGGCAGTGAAGCAGGGAAG-3') and 1924Rsuprabasin for pGFP/suprabasin (aa 133-612).
Oligonucleotides 427Fsuprabasin and 1304Rsuprabasin were used to
generate pGFP/suprabasin (aa 133-425) and RI5'suprabasin and
SalI3'suprabasin for the full-length pGFP/suprabasin (aa 1-700). All
PCR reactions were performed for 30 cycles of denaturation at 94 °C
for 45 s, annealing at 55 °C for 45 s, and extension at
68 °C for 90 s.
Cell Culture and Transfection--
Primary mouse keratinocytes
were isolated from BALB/c trypsinized newborn mouse skins and grown in
Eagle's minimal essential medium lacking Ca2+ with 8%
Chelex-treated fetal bovine serum (24-26). Ca2+
concentrations were determined by analysis in an atomic absorption spectrophotometer. Unless otherwise indicated, the Ca2+
concentration of the medium was adjusted to 0.05 mM to
maintain a basal cell-like population of undifferentiated cells. Cells were treated with different kinase inhibitors at 10 µM
concentration for specific time periods. The inhibitors used were: the
PKC inhibitor GF109203X (GF, bisindolylmaleimide I, Alexis), the PKA
inhibitor H89
(N-[2-99p-bromocinnamyl-0-amino-0-ethyl]-5-isoquinolinesulfonamide, Alexis), or a CaM kinase II inhibitor (KN62,
1-[N,O-bis-(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, Calbiochem). Primary mouse keratinocytes were transfected using the
FuGENE6 reagent (Roche Molecular Biochemicals). Typically, 0.5 µg of
GFP/suprabasin, GFP/suprabasin truncated constructs, or pEGFP-C1
control construct were transfected into cells plated and cultured in
two-well chamber slides coated with rat tail collagen (0.1 mg/ml).
After 4 h incubation, the cells were treated with 15% glycerol in
KSF medium (Invitrogen) for 3.5 min and then maintained in medium with
0.05, 0.12, or 1.4 mM Ca2+.
Human keratinocytes (NHEK) were cultured in vitro in
serum-free keratinocyte medium as described by Jang et al.
(27), and were induced to differentiate by increasing the
Ca2+ concentration in the media to 1.4 mM or by
treatment with the PKC inducer TPA (100 nM). Cells were
cultured for different time periods as indicated.
Northern Blots--
Total RNA were isolated from mouse primary
basal and suprabasal keratinocytes, and mouse and human keratinocytes
differentiated in vitro using TRIzol (Invitrogen). The RNA
samples (1-3 µg) were electrophoresed in 1.2%
agarose/methymercuryhydroxide gels, electroblotted to nylon membranes,
and hybridized according to Church and Gilbert (28). mRNA blots for
human and mouse adult tissues were purchased from
Clontech and used according to instructions. The
probes used were 262-bp coding (mouse) and 500-bp coding (human)
suprabasin cDNAs. After exposure, hybridized probes were removed by
boiling filters in 0.1× SCC, 0.1% SDS. All blots were re-hybridized
with a cDNA probe for glyceraldehyde-3-phosphate dehydrogenase (29) to control for RNA loading and integrity.
Radioactive in Situ Hybridization--
RNA probes corresponding
to the sense and antisense strands of mouse suprabasin partial cDNA
(262 bp from 2014 to 2277) (pGEMT-easy/3'suprabasin) were prepared
using T7 and Sp6 RNA polymerase and 35S-labeled UTP.
Sections of mouse embryos were subjected to in situ
hybridization as described by Mackem and Mahon (Ref. 30 and molecular histology).
Suprabasin Expression, Purification, and Structure
Predictions--
The region coding for amino acids 1-612 was
subcloned into a pET28b vector to generate a recombinant protein. The
recombinant clone was overexpressed in BL21(DE3)RIL. The recombinant
protein contains a His tag and a T7 tag at the NH2 terminus
of the protein. The soluble and insoluble forms of the recombinant
protein were purified over a nickel-nitrilotriacetic acid-agarose
column (Qiagen) and Mono Q-FPLC. We analyzed the predicted protein
sequence using the ISREC search tools (www.isrec.isb-sib.ch/), the
Baylor College of Medicine Search launcher
(searchlauncher.bcm.tmc.edu/), and MacVector 6.5.3.
TGase Assay and Western Analysis--
To examine the
cross-linking activity by TGase, 300 ng of recombinant suprabasin (aa
1-612) was incubated with 0.4 µg and 1.2 µg of TGase 2 (Sigma) or
3 µg and 6 µg of TGase 3 in buffer containing 20 mM
CaCl2 and 5 mM dithiothreitol for 30 min at
37 °C. The reaction was stopped by addition of 6× SDS loading dye and heated at 90 °C for 3min. The products were separated on 4-20% SDS-polyacrylamide gel. Involucrin was included as a positive control
for the TGase activity. The gel was electroblotted to a polyvinylidene
difluoride membrane, and an antibody against T7 (Invitrogen) was used
in Western analysis to determine the oligomerization of suprabasin by
TGase.
 |
RESULTS |
Cloning and Characterization of Suprabasin cDNA--
SSH, a
PCR-based cDNA subtraction method (Ref. 31;
Clontech) was used to compare the basal and
suprabasal mRNA populations from neonatal epidermis. From a screen
of 96 hybridization selected clones, the sequence of the candidate
cDNAs was used to search the data bases, and to determine whether
the isolated clones were novel and/or whether they contained motifs
found in other factors. Several novel genes as well as known
suprabasal-specific genes were identified. We used the partial
cDNAs of a selected number of novel genes as probes in Northern
blots containing poly(A)+ mRNAs from basal and
suprabasal cells separated by Percoll gradients (23). Only the
cDNAs that hybridized exclusively with the suprabasal mRNA
fraction were further characterized. We utilized 5'-RACE methods to
obtain the full-coding sequence of the novel suprabasal-specific gene
that we termed suprabasin (Fig.
1A). A data base comparison with the full-length or repeat region sequence of suprabasin using the
program BLAST did not reveal any homology to known protein sequences.
The search of publicly available EST data bases revealed homology to a
several overlapping mouse EST sequences (AA530183, AA727702, and
791703). By searching the data base of human genomic sequences, we
identified a region in human chromosome 19 with homology to the mouse
suprabasin cDNA sequence. To amplify the human homologue of
suprabasin, we designed the oligonucleotides corresponding the
NH2- and COOH-terminal region of suprabasin, which were
conserved between the mouse cDNA sequence and the human genomic DNA
sequence (forward, 5'-GAAGGGATCAACCGAGGGCTGAGCAATGCAG-3'; reverse, 5'-GCTCATAATGGGGTCAACCAAGCCAGCAAGG-3'). Using a RT-PCR method, we amplified a 500-bp DNA fragment from human skin RNA. Sequencing results showed that amplified fragment is identical to human
EST cDNA BG742735. We performed Northern analysis of human
suprabasin using the 0.5-kb amplified DNA fragment as a probe.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 1.
Nucleotide and amino acid sequences of mouse
suprabasin. A, the nucleotide sequence of mouse
suprabasin cDNA (2277 bp) was aligned with the predicted open
reading frame amino acid sequence. Three open
triangles indicate the sites of splicing (exon/intron
boundaries), and the double-underlined nucleotides indicate
the canonical poly(A) addition signal. B, the amino acid
sequence of mouse suprabasin has been aligned to show the central
repetitive domain region (boxed). The dotted
line indicates the different repeat sequence region. The
shaded residues highlight a predicted transmembrane region
domain. The underlined sequences in the COOH-terminal domain
indicate potential protein kinase C phosphorylation sites.
Numbers in parentheses at the right
side indicate number of residues.
|
|
The 2277-bp mouse suprabasin transcript included 30 bp of
5'-untranslated sequence and 144 bp of 3'-untranslated sequence. The
transcript had a polyadenylation signal at 2251 bp, a poly (A)+ tail, and one putative open reading frame that
translated into a 700-amino acid protein. Analysis of the open reading
frame sequence by ISREC search tools (www.isrec.isb-sib.ch/), the
Baylor College of Medicine Search launcher
(searchlauncher.bcm.tmc.edu/), and MacVector 6.5.3. predicted a protein
with a mass of 72 kDa and an isoelectric point for the unmodified
protein of 6.85. The programs also identified a potential transmembrane
domain in the amino-terminal region (shaded area
in Fig. 1B) and a series of glycine- and histidine-rich short tandem repeats in the central domain (boxed
area in Fig. 1B). Potential PKC phosphorylation
sites were identified (underlined in Fig. 1B).
Comparison of the open reading frame to the data bases also revealed 2 casein kinase II phosphorylation sites and 73 potential
N-myristoylation sites. Analysis of the nucleotide sequence
surrounding the AUG initiator codon for the suprabasin open reading
frame (AACAACATGT) conformed to the consensus
sequence for initiation of translation
(GCCACCAUGG) in having a purine (A) at
position 3, but lacked the consensus G found at position +4 (32).
Further analysis must be done to determine whether there is a
modulation of translation of suprabasin as a result of the primary
sequence surrounding the AUG codon.
In Situ and Northern Blot Analysis of Suprabasin
Expression--
In situ hybridization of sagittal sections
of E17.5 mouse embryos showed epidermal-specific expression (Fig.
2A). Higher magnification showed that the expression detected with the antisense mouse suprabasin probe was specific to the suprabasal-differentiated layers of interfollicular trunk and tail epidermis (Fig. 2, D and
G). Expression was also detected in the stratified layers in
the tongue and palate (Fig. 2J). In situ
hybridization of an adult mouse mixed tissue block detected expression
only in stomach tissue, with no detectable expression in kidney, liver,
brain, spleen, or heart (data not shown). No expression was observed
when using the control sense suprabasin probe (Fig. 2, B,
E, H, and K).

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of suprabasin. In
situ hybridization was performed with antisense (A) and
sense (B) suprabasin probes on sagittal sections of E17.5
mouse embryos. C, hematoxylin and eosin
(H+E) staining of E17.5 sagittal sections. D,
G, and J, 20× magnification of trunk skin
(D), tail skin (G), and palate (J)
with antisense suprabasin. Corresponding hybridization with sense
suprabasin (E, H, and K) and
hematoxylin and eosin stain (F, I, and
L). hf, hair follicle; p, palate;
t, tongue.
|
|
Analysis of suprabasin expression in mouse primary basal and suprabasal
keratinocytes isolated by discontinuous Percoll gradient showed
specific expression of the suprabasin 2.2-kb transcript in the
differentiated epidermal cell layers (Fig.
3A). We identified a smaller
0.7-kb transcript that was also exclusively expressed in the
differentiated layer.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 3.
Northern blot analysis of mouse
suprabasin. A, expression of suprabasin in the
epidermis of newborn mice. Northern blot of poly(A)+
mRNA (2 µg) from basal and differentiated keratinocytes isolated
by discontinuous Percoll gradient from neonatal epidermis. The position
of the 18 and 28 S ribosomal RNAs are shown. B, expression
of suprabasin in primary mouse keratinocytes cultured and
differentiated in vitro by addition of Ca2+.
C, time course of suprabasin expression in cultured mouse
keratinocytes and after 24 h of treatment with different kinase
inhibitors: GF (PKC inhibitor), H89 (PKA inhibitor), or KN62 (CaM
kinase II inhibitor). D, mouse embryonic mRNA blot
(Clontech). Panel shows 2 µg of
poly(A)+ per lane from four embryonic developmental stages
(7-, 11-, 15-, and 17-day embryos). RNA size marker is indicated on the
left. E, adult multiple tissue mRNA Northern
blot (Clontech). Tissue sample is indicated
above each lane. All blots were hybridized with 262-bp
suprabasin, glyceraldehyde-3-phosphate dehydrogenase, and PL-1
(placenta lactogen 1) probes, as indicated.
|
|
The 0.7-kb transcript detected by the suprabasin-specific probe in
Northern analysis was amplified by RACE using a suprabasin-specific oligonucleotide corresponding to 3'-untranslated region (bp
2133-2277). A 0.7-kb fragment was cloned into the pGEMT-easy vector,
and by sequence analysis we determined that this shorter mRNA
results from an alternative splicing that occurs between bp 384 and
1993, resulting in a transcript that lacks the coding region for the tandem repeats (Fig. 5B).
The expression of suprabasin was also studied in keratinocytes cultured
in vitro (Fig. 3, B and C). Suprabasin
expression was detected only after the keratinocytes were induced to
differentiate in vitro by incrementing Ca2+
concentration. A more detailed time course of induction showed that
suprabasin expression was already detectable 4 h after the Ca2+ switch with high expression being reached after
24 h in culture. Treatment of cultured cells with different kinase
(PKC, PKA, CaM kinase II) inhibitors showed a specific and complete
repression of suprabasin expression with PKC inhibitor treatment (GF;
Fig. 3C). This is reminiscent of results observed for other
late epidermal differentiation factors, where expression is dependent
on the PKC signaling pathway. No effect on expression was seen with
treatment with a PKA inhibitor (H89) and a reproducible partial
inhibition was observed with an inhibitor for the CaM kinase II (KN62)
(Fig. 3C). Mouse suprabasin expression was assessed during
embryonic development by Northern blot analysis (Fig. 3D).
Expression was detected at E15 coinciding with stratification of the
epidermis and dramatically increased by E17. The early detection at E7
was predicted to be caused by extra-embryonic tissue contribution that
is present in the E7 sample. The extra-embryonic contribution in sample
E7 was corroborated by re-hybridizing the Northern blot with PL-1, a
placental specific marker. Other sites of expression detected from a
dot blot analysis of different adult tissues were the uterus and
thyroid (data not shown), whereas no expression was found in heart,
brain, spleen, lung, liver, smooth muscle, or kidney (Fig.
3E).
As mentioned above, we also cloned a partial human suprabasin cDNA
and analyzed the expression pattern by Northern blots. We found that
human suprabasin is expressed as two transcripts of 2.2 and 1.1 kb . The expression was detected in the skin and in human keratinocytes
(NHEK) cultured in vitro (Fig.
4A). A time course of
induction for human suprabasin in NHEK showed that, as for the mouse
primary keratinocytes, the expression was restricted to
cells induced to differentiate in vitro (Fig.
4B). The expression could also be induced by treatment of
the cells with TPA, an activator of the PKC signaling pathway. Northern
blot analysis of different human tissues showed expression in the
esophagus, uterus, and thymus (Fig. 4C).

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 4.
Northern blot analysis of human suprabasin.
A, expression of suprabasin in NHEK. Northern blot of RNA (2 µg) from human skin, commercial preparation of human skin
(Invitrogen), and human keratinocytes cultured in vitro in
1.4 mM Ca2+ (NHEK). The position of
the 18 S ribosomal RNA is shown. B, time course of
expression of suprabasin in human keratinocytes cultured and
differentiated in vitro by addition of Ca2+.
L, cultured in 0.05 mM Ca2+
concentration to maintain basal proliferative conditions. H,
keratinocytes induced to differentiate in vitro by addition
of Ca+ to 1.4 mM and cultured for different
time periods (H1, 1 day; H3, 3 days;
H6, 6 days; H9, 9 days. Keratinocytes were
treated with TPA (100 nM) and cultured for 1 (T1) and 3 (T3) days. C, human
multiple tissue mRNA blots (Clontech and
Invitrogen); 2 µg of poly(A)+ per lane from tissues
indicated above each lane. RNA size markers are indicated on
the left. All blots were hybridized with a human 0.5-kb
suprabasin probe and glyceraldehyde-3-phosphate dehydrogenase probe as
indicated.
|
|
Chromosomal Localization and Structure of Mouse Suprabasin--
An
initial experiment resulted in specific labeling of the proximal region
of which was believed to be chromosome 7 on the basis of
4,6-diamidino-2-phenylindole staining. A second experiment was
conducted in which a probe specific for the telomeric region of
chromosome 7 was co-hybridized with the genomic BAC suprabasin probe.
This experiment resulted in the specific labeling of the telomere and
the proximal portion of chromosome 7 (Fig.
5A). Measurements of 10 specifically labeled chromosomes 7 demonstrated that suprabasin is
located at a position 19% of the distance from the
heterochromatic-euchromatic boundary to the telomere of chromosome 7, an area that corresponds to band 7B2-7B3. A total of 80 metaphase
cells were analyzed with 72 exhibiting specific labeling.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Chromosomal localization and genomic
structure of mouse suprabasin. A, FISH localizes the
mouse suprabasin gene to chromosome 7. Asterisks indicated
the positive spots on the chromosomes 7 to band 7B2-7B3 (indicated by
arrow in the schematic map of chromosome 7). B,
sequence and genomic analysis of a BAC clone showed that mouse
suprabasin consists of four exons and three introns. The small
suprabasin transcript (0.7 kb) results from alternative splicing as
indicated. Nucleotides (bp) are shown in parentheses.
|
|
Search through the human genomic data bases localized only one site
with high homology to the mouse suprabasin sequence to chromosome
19q13.1 (AC002389). This region in chromosome 19 is syntenic to the
region in the mouse chromosome 7 where suprabasin was localized by FISH
mapping. Analysis of the homologous genomic human region predicted
exons of good and excellent quality.
As can be seen in the Northern blots with both human and mouse tissues,
the suprabasin presents two alternatively spliced transcripts (2.2 and
0.7 kb in the mouse and 2.2 and 1.1 kb in the human). By comparison of
the gene and cDNA sequences in the mouse, we determined the
intronic and coding regions of suprabasin (Fig. 5B). The
intron sizes are 1339 bp for intron 1, 121 bp for intron 2, and 918 bp
for intron 3. Alternative splicing between bp 384 and 1993 generates
the shorter 0.7-kb splice variant that lacks the coding region for the
tandem repeats (Fig. 5B). Analysis of the proximal promoter
region showed that it is AT-rich, lacks CpG islands, and contains a
canonical TATA box, and revealed several potential transcription factor
binding sites for AP1 and Sp1 (data not shown).
Expression of GFP/Suprabasin in Transfected Mouse
Keratinocytes--
To study the intracellular localization of
suprabasin, we transfected GFP/suprabasin full-length and truncated
fusion constructs into primary mouse keratinocytes (Fig.
6). Intracellular localization of GFP
fusion proteins was observed by direct fluorescence microscopy. The
location of the nucleus was apparent by propidium iodide
(PI) staining. The schematic representation of the GFP
fusion constructs is in the left panel of Fig. 6
and indicates the suprabasin residues that are fused to GFP.
Full-length suprabasin localizes in a highly patch-like expression
pattern throughout the cytoplasm. To examine whether suprabasin
co-localized with cellular organelles, we performed staining for
mitochondria with MitoTracker (mitochondrion-selective stains,
Molecular Probes) and immunocytochemistry with LAMP1 and -2 (lysosome-associated membrane glycoprotein, Santa Cruz). Neither co-localized with GFP/suprabasin expression in the transfected cells
(data not shown). We also tested a series of truncated fusion constructs (Fig. 6). The expression of NH2-terminal region
GFP/suprabasin-(1-144) resulted in expression throughout the cytoplasm
that lacked the patchy phenotype of the COOH-terminal truncated (aa
1-612) or full-length (aa 1-700) fusion constructs. Expression of
GFP/suprabasin-(133-425), which contains the first tandem repeat
domain had effects on cell viability (data not shown), whereas the
GFP/suprabasin-(133-612) that contained the complete tandem repeat
region resulted in restricted expression around the nucleus. The
expression of NH2 terminus with a partial tandem repeat
domain of suprabasin-(1-425) caused a strong dense expression in the
cytoplasm. This expression was distinct from the C-terminal truncated
(aa 1-612) or the full-length (aa 1-700). GFP control was detected as
bright green fluorescence throughout the cell (Fig. 6).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Expression of GFP/suprabasin fusion proteins
in primary mouse keratinocytes. Figure is the schematic
representation of full-length and truncated GFP/suprabasin fusion
constructs transfected into mouse keratinocytes. The repeat domain
region is represented as shaded box with the
dotted line indicating the divergent repeat
sequence and numbers indicating the amino acid residues in
each construct. Middle panel, GFP,
GFP/suprabasin, and GFP/suprabasin truncated proteins were expressed in
keratinocytes differentiated in vitro with 0.12 mM Ca2+ and visualized by direct fluorescence
microscopy with fluorescein isothiocyanate filter. The propidium iodide
(PI) counterstain indicates the location of the nucleus
within the cells (shown on right panel).
|
|
Transglutaminase Assays--
We tested whether recombinant
suprabasin (aa 1-612) was a substrate for TGase activity.
Cross-linking assays were performed with TGase 2 and 3, with
recombinant mouse suprabasin. TGase 3 is expressed in epithelia and is
a proven participant in CE assembly. The monomeric recombinant
suprabasin (aa 1-612) is shown in Fig. 7. After incubation at 37 °C with
either TGase 2 (0.4 or 1.2 µg) or TGase 3 (3 or 9 µg), the samples
were run in a SDS denaturing gel and transferred to a polyvinylidene
difluoride membrane. Western blot analysis using an antibody against
the T7 epitope (present in the amino terminus of suprabasin from the
pET28 construct) showed that, after incubation with either TGase 2 or
TGase 3, the monomeric suprabasin was cross-linked into a high
molecular weight form (indicated by arrow in Fig. 7).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Cross-linking assay of mouse suprabasin by
TGase 2 and 3. Recombinant suprabasin (aa 1-612) was incubated
with 0.4 and 1.2 µg of TGase 2, or 3 and 9 µg of TGase 3 for 30 min
at 37 °C (described under "Experimental Procedures"). A Western
blot was performed with anti-T7 antibody. Arrow indicates
the cross-linked suprabasin. M, lane for high molecular mass
markers (SeeBlue, Invitrogen). Numbers on left
side indicate molecular mass in kDa.
|
|
 |
DISCUSSION |
Identification of the diverse precursors that contribute to CE
formation will help us elucidate the complex series of steps that are
required for the formation of a functional biological barrier in the
stratified epithelia. This highly cross-linked insoluble structure that
protects individuals is essential for well being, and disruptions of
its formation have been correlated with skin diseases (5).
Recently, through the use of different approaches and methodologies
such as subtractive hybridization, rapid analysis of gene expression,
positional cloning, and EST data base searches (17-21), several new
epidermal-specific genes and CE precursors have been identified. In
this report we present data on the identification and characterization
of a novel gene with a potential role in epidermal stratification. The
cDNA was initially identified by performing an SSH procedure. From
the in situ hybridization data, we show that the suprabasin
mRNA is restricted and highly expressed in the suprabasal layers of
the neonatal epidermis. The suprabasin probe identifies transcripts of
2.2 and 0.7 kb in mouse RNA from stratified epithelial tissues and in
extra-embryonic tissue (E7). The expression of the suprabasin
transcripts in cultured keratinocytes was shown to be dependent on PKC
signaling, because specific inhibition of PKC abolished the
differentiation-induced expression. Alternatively, we also showed that
the human suprabasin transcripts could be induced by treatment of NHEK
cells with the PKC inducer, TPA. This response to TPA treatment has
been shown for other epidermal late differentiation markers (33, 34),
emphasizing the role of PKC in the Ca2+-mediated induction
of suprabasin during differentiation.
Chromosomal FISH localized the mouse suprabasin gene to chromosome 7, at band 7B2-7B3. Data base searches identified only one homolog gene
in the human genomic data bases in chromosome 19q13.1, in a region that
is syntenic to the region where the mouse suprabasin gene was localized.
The 2.2-kb suprabasin transcript contains an open reading frame, which
encodes a protein of 700 amino acids that is glycine-rich (~20%) and
has a high content of basic residues such as lysine, histidine, and
arginine. The deduced suprabasin protein sequence shares structural
features with other differentiation markers such as involucrin and
loricrin, and somewhat with sciellin, although suprabasin lacks a LIM
domain sequence (10). Based on structural features, suprabasin can be
divided into three domains: an amino-terminal region that contains a
potential transmembrane sequence, a central domain with tandem repeats,
and a carboxyl domain. 56% of the repetitive region in suprabasin is
composed of glycine, glutamine, histidine, and alanine residues. The
glutamine residues may be serving as acceptors of
glutamyl-lysyl isopeptide bonds mediated by transglutaminases. TGases
are Ca2+-dependent enzymes that catalyze the
formation of -( -glutamyl)lysine isopeptide cross-links and/or in
the covalent incorporation of polyamines and histamine. These covalent
cross-links often result in the oligomerization of substrate proteins.
Our results show that the recombinant suprabasin protein is a substrate
for both, tissue TGase 2 and the epidermal TGase 3. Although we
demonstrated the oligomerization of suprabasin in vitro by
TGases, we did not detect the presence of previously determined
transglutaminase target sequences in suprabasin (6, 7). It remains to
be determined which are the specific residues that are reactive in suprabasin, whether these are also utilized in vivo, and
whether the endogenous suprabasin is incorporated to the CE.
The relevance of each of the domains in the full-length suprabasin was
shown with the intracellular localization of the GFP/suprabasin full-length and truncated proteins in transfected keratinocytes. The
full-length GFP/suprabasin showed a highly patched phenotype that did
not co-localized with mitochondria or lysosomes. This patched phenotype
was absent when the protein was truncated to include only the
amino-terminal domain, which presented a homogenous cytoplasmic
distribution. The patched expression was shown to be caused at least in
part by the repeat region, because the GFP/suprabasin-(1-425) had also
a patched phenotype, although with a more perinuclear restricted
expression. In addition, the mouse smaller transcript (0.7 kb) contains
an open reading frame that shares the amino-terminal domain with the
full-length suprabasin protein, but lacks the repeat domain. It will be
of great interest to determine the role of the spliced transcript in
the overall process of epidermal differentiation.
 |
ACKNOWLEDGEMENTS |
We thank Dr. E. Ralston and the members of
the NIAMS Image Facility for help with the cell microscopy. We also
thank Drs. P. Steinert, K. Boeshans, and B. Advazi for supplying active
TGase 3. We are grateful to Noelia Rodriguez and Will Idler for
technical assistance, Rick Dreyfuss for photographic assistance, and to Dr. Ulrike Lichti for Ca2+ concentration determinations and
providing reagents.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY115494
¶
To whom correspondence should be addressed: Developmental Skin
Biology Unit, Bldg. 50, Rm. 1525, NIAMS, National Institutes of Health,
Bethesda, MD 20892. Tel.: 301-402-2888; Fax: 301-435-7910; E-mail: morasso@nih.gov.
Published, JBC Papers in Press, September 12, 2002, DOI 10.1074/jbc.M205380200
 |
ABBREVIATIONS |
The abbreviations used are:
CE, cornified
envelope;
EDC, epidermal differentiation complex;
E, embryonic day;
PKA, cAMP-dependent protein kinase;
PKC, protein kinase C;
FISH, fluorescence in situ hybridization;
SSH, suppression
subtractive hybridization;
NHEK, human keratinocyte;
CaM, calmodulin;
GFP, green fluorescent protein;
RACE, rapid amplification of cDNA
ends;
TPA, 12-O-tetradecanoylphorbol-13-acetate;
TGase, transglutaminase;
EST, expressed sequence tag;
aa, amino acid(s);
GF, GF109203X (bisindolylmaleimide I);
H89, N-[2-99p-bromocinnamyl-0-amino-0-ethyl]-5-isoquinolinesulfonamide;
KN62, 1-[N,O-bis-(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]- 4-phenylpiperazine.
 |
REFERENCES |
| 1.
|
Fuchs, E.,
and Byrne, C.
(1994)
Curr. Opin. Genet. Dev.
4,
725-736[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Eckert, R. L.,
and Welter, J. F.
(1996)
Mol. Biol. Rep.
23,
59-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Steinert, P. M.,
Marekov, L. N.,
and Parry, D. A.
(1999)
J. Biol. Chem.
274,
1657-1666[Abstract/Free Full Text]
|
| 4.
|
Kalinin, A.,
Marekov, L. N.,
and Steinert, P. M.
(2001)
J. Cell Sci.
114,
3069-3070[Free Full Text]
|
| 5.
|
Presland, R. B.,
and Dale, B. A.
(2000)
Crit. Rev. Oral Biol. Med
11,
383-408[Abstract/Free Full Text]
|
| 6.
|
Robinson, N. A.,
Lapic, S.,
Welter, J. F.,
and Eckert, R. L.
(1997)
J. Biol. Chem.
272,
12035-12046[Abstract/Free Full Text]
|
| 7.
|
Steinert, P. M.,
and Marekov, L. N.
(1997)
J. Biol. Chem.
272,
2021-2030[Abstract/Free Full Text]
|
| 8.
|
Volz, A.,
Korge, B. P.,
Compton, J. G.,
Ziegler, A.,
Steinert, P. M.,
and Mischke, D.
(1993)
Genomics
18,
92-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Mischke, D.,
Korge, B. P.,
Marenholz, I.,
Volz, A.,
and Ziegler, A.
(1996)
J. Invest. Dermatol.
106,
989-992[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Champliaud, M. F.,
Burgeson, R. E.,
Jin, W.,
Baden, H. P.,
and Olson, P. F.
(1998)
J. Biol. Chem.
273,
31547-31554[Abstract/Free Full Text]
|
| 11.
|
Maatta, A.,
Ruhrberg, C.,
and Watt, F. M.
(2000)
J. Biol. Chem.
275,
19857-19865[Abstract/Free Full Text]
|
| 12.
|
Aho, S.,
McLean, W. H., Li, K.,
and Uitto, J.
(1998)
Genomics
48,
242-247[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Jarnik, M.,
de Viragh, P. A.,
Scharer, E.,
Bundman, D.,
Simon, M. N.,
Roop, D. R.,
and Steven, A. C.
(2002)
J. Invest. Dermatol.
118,
102-109[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Maatta, A.,
DiColandrea, T.,
Groot, K.,
and Watt, F. M.
(2001)
Mol. Cell. Biol.
21,
7047-7053[Abstract/Free Full Text]
|
| 15.
|
Djian, P.,
Easley, K.,
and Green, H.
(2000)
J. Cell Biol.
151,
381-388[Abstract/Free Full Text]
|
| 16.
|
Koch, P. J.,
de Viragh, P. A.,
Scharer, E.,
Bundman, D.,
Longley, M. A.,
Bickenbach, J.,
Kawachi, Y.,
Suga, Y.,
Zhou, Z.,
Huber, M.,
Hohl, D.,
Kartasova, T.,
Jarnik, M.,
Steven, A. C.,
and Roop, D. R.
(2000)
J. Cell Biol.
151,
389-400[Abstract/Free Full Text]
|
| 17.
|
Zhao, X. P.,
and Elder, J. T.
(1997)
Genomics
45,
250-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Marenholz, I.,
Zirra, M.,
Fischer, D. F.,
Backendorf, C.,
Ziegler, A.,
and Mischke, D.
(2001)
Genome Res.
11,
341-355[Abstract/Free Full Text]
|
| 19.
|
Marshall, D.,
Hardman, M. J.,
Nield, K. M.,
and Byrne, C.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
13031-13036[Abstract/Free Full Text]
|
| 20.
|
Wang, A.,
Johnson, D. G.,
and MacLeod, M. C.
(2001)
Genomics
73,
284-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Makino, T.,
Takaishi, M.,
Morohashi, M.,
and Huh, N. H.
(2001)
J. Biol. Chem.
276,
47445-47452[Abstract/Free Full Text]
|
| 22.
|
Diatchenko, L.,
Lukyanov, S.,
Lau, Y. F.,
and Siebert, P. D.
(1999)
Methods Enzymol.
303,
349-380[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lichti, U.,
and Yuspa, S. H.
(1988)
Cancer Res.
48,
74-81[Abstract/Free Full Text]
|
| 24.
|
Hennings, H.,
Michael, D.,
Cheng, C.,
Steinert, P.,
Holbrook, K.,
and Yuspa, S. H.
(1980)
Cell
19,
245-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Yuspa, S. H.,
Kilkenny, A. E.,
Steinert, P. M.,
and Roop, D. R.
(1989)
J. Cell Biol.
109,
1207-1217[Abstract/Free Full Text]
|
| 26.
|
Morasso, M. I.,
Jamrich, M.,
and Sargent, T. D.
(1994)
Dev. Biol.
162,
267-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Jang, S. I.,
Steinert, P. M.,
and Markova, N. G.
(1996)
J. Biol. Chem.
271,
24105-24114[Abstract/Free Full Text]
|
| 28.
|
Church, G. M.,
and Gilbert, W.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
1991-1995[Abstract/Free Full Text]
|
| 29.
|
Fort, P.,
Marty, L.,
Piechaczyk, M.,
el Sabrouty, S.,
Dani, C.,
Jeanteur, P.,
and Blanchard, J. M.
(1985)
Nucleic Acids Res.
13,
1431-1442[Abstract/Free Full Text]
|
| 30.
|
Mackem, S.,
and Mahon, K. A.
(1991)
Development
112,
791-806[Abstract]
|
| 31.
|
Diatchenko, L.,
Lau, Y. F.,
Campbell, A. P.,
Chenchik, A.,
Moqadam, F.,
Huang, B.,
Lukyanov, S.,
Lukyanov, K.,
Gurskaya, N.,
Sverdlov, E. D.,
and Siebert, P. D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6025-6030[Abstract/Free Full Text]
|
| 32.
|
Kozak, M.
(1991)
J. Biol. Chem.
266,
19867-19870[Free Full Text]
|
| 33.
|
Dlugosz, A. A.,
and Yuspa, S. H.
(1993)
J. Cell Biol.
120,
217-225[Abstract/Free Full Text]
|
| 34.
|
Dlugosz, A. A.,
and Yuspa, S. H.
(1994)
J. Invest. Dermatol.
102,
409-414[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Touma, V. Antonini, M. Kumar, S. L. Osborn, A. M. Bobenchik, D. B. Keskin, J. E. Connolly, M. J. Grusby, E. L. Reinherz, and L. K. Clayton
Functional Role for I{kappa}BNS in T Cell Cytokine Regulation As Revealed by Targeted Gene Disruption
J. Immunol.,
August 1, 2007;
179(3):
1681 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Reigstad, S. J. Hultgren, and J. I. Gordon
Functional Genomic Studies of Uropathogenic Escherichia coli and Host Urothelial Cells when Intracellular Bacterial Communities Are Assembled
J. Biol. Chem.,
July 20, 2007;
282(29):
21259 - 21267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hwang and M. I. Morasso
The Novel Murine Ca2+-binding Protein, Scarf, Is Differentially Expressed during Epidermal Differentiation
J. Biol. Chem.,
November 28, 2003;
278(48):
47827 - 47833.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|